VKTX stock icon

Viking Therapeutics
VKTX

$50.43
0.57%
 

About: Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Employees: 28

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 22 analysts
0
News positive %
of 31 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

589% more first-time investments, than exits

New positions opened: 193 | Existing positions closed: 28

550% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 13 (+11) [Q1 2024]

361% more capital invested

Capital invested by funds: $1.42B [Q4 2023] → $6.54B (+$5.12B) [Q1 2024]

85% more funds holding

Funds holding: 195 [Q4 2023] → 360 (+165) [Q1 2024]

39% more call options, than puts

Call options by funds: $582M | Put options by funds: $420M

8% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 84

3.3% less ownership

Funds ownership: 76.32% [Q4 2023] → 73.01% (-3.3%) [Q1 2024]

Research analyst outlook

22 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$35
31%
downside
Avg. target
$103
104%
upside
High target
$138
174%
upside

22 analyst ratings

22 positive
100%
neutral
0%
negative
0%
Truist Securities
Joon Lee
138%upside
$120
Buy
Maintained
17 Jun 2024
Maxim Group
Naz Rahman
138%upside
$120
Buy
Reiterated
4 Jun 2024
HC Wainwright & Co.
Joseph Pantginis
78%upside
$90
Buy
Reiterated
4 Jun 2024
Raymond James
Steven Seedhouse
130%upside
$116
Strong Buy
Upgraded
16 May 2024
Truist Securities
Joon Lee
138%upside
$120
Buy
Reiterated
16 May 2024

Financial journalist opinion

Based on 31 articles about VKTX published over the past 30 days